Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Value of C-reactive protein in predicting left ventricular remodelling in patients with a first ST-segment elevation myocardial infarction.

Swiatkiewicz I, Kozinski M, Magielski P, Fabiszak T, Sukiennik A, Navarese EP, Odrowaz-Sypniewska G, Kubica J.

Mediators Inflamm. 2012;2012:250867. doi: 10.1155/2012/250867. Epub 2012 Sep 2.

2.

Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.

Wang TJ, Wollert KC, Larson MG, Coglianese E, McCabe EL, Cheng S, Ho JE, Fradley MG, Ghorbani A, Xanthakis V, Kempf T, Benjamin EJ, Levy D, Vasan RS, Januzzi JL.

Circulation. 2012 Sep 25;126(13):1596-604. Epub 2012 Aug 20.

3.

Role of thromboxane receptor in C-reactive protein-induced thrombosis.

Grad E, Pachino RM, FitzGerald GA, Danenberg HD.

Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2468-74. doi: 10.1161/ATVBAHA.112.256073. Epub 2012 Aug 9.

4.

C-reactive Protein as a Predictor of Adverse outcome in Patients with Acute Coronary Syndrome.

Sheikh AS, Yahya S, Sheikh NS, Sheikh AA.

Heart Views. 2012 Jan;13(1):7-12. doi: 10.4103/1995-705X.96660.

5.

Reducing residual risk in secondary prevention of cardiovascular disease.

Stone NJ.

Circulation. 2012 Apr 24;125(16):1958-60. doi: 10.1161/CIRCULATIONAHA.112.101782. Epub 2012 Mar 29. No abstract available.

6.

Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction.

Swiatkiewicz I, Kozinski M, Magielski P, Gierach J, Fabiszak T, Kubica A, Sukiennik A, Navarese EP, Odrowaz-Sypniewska G, Kubica J.

Inflamm Res. 2012 Jul;61(7):725-34. doi: 10.1007/s00011-012-0466-2. Epub 2012 Mar 24.

7.

Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2012 Jan 3;125(1):188-97. doi: 10.1161/CIR.0b013e3182456d46. No abstract available. Erratum in: Circulation. 2012 Jun 5;125(22):e1001.

8.

C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes.

Forte L, Cimmino G, Loffredo F, De Palma R, Abbate G, Calabrò P, Ingrosso D, Galletti P, Carangio C, Casillo B, Calabrò R, Golino P.

Int J Cardiol. 2011 Oct 6;152(1):7-12. doi: 10.1016/j.ijcard.2011.05.062. Epub 2011 Jul 26.

PMID:
21794939
9.

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data.

C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC), Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, Engert JC, Clarke R, Davey-Smith G, Nordestgaard BG, Saleheen D, Samani NJ, Sandhu M, Anand S, Pepys MB, Smeeth L, Whittaker J, Casas JP, Thompson SG, Hingorani AD, Danesh J.

BMJ. 2011 Feb 15;342:d548. doi: 10.1136/bmj.d548.

10.

Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.

Sawicki M, Sypniewska G, Kozinski M, Gruszka M, Krintus M, Obonska K, Pilaczynska-Cemel M, Kubica J.

Eur J Clin Invest. 2011 Jun;41(6):667-71. doi: 10.1111/j.1365-2362.2010.02457.x. Epub 2011 Jan 12.

PMID:
21226709
11.

CRP levels are higher in patients with ST elevation than non-ST elevation acute coronary syndrome.

Habib SS, Kurdi MI, Al Aseri Z, Suriya MO.

Arq Bras Cardiol. 2011 Jan;96(1):13-7. Epub 2010 Dec 3. English, Portuguese, Spanish.

12.

C-reactive protein is a mediator of cardiovascular disease.

Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ.

Eur Heart J. 2010 Sep;31(17):2087-91. doi: 10.1093/eurheartj/ehq238. Epub 2010 Aug 3. Review.

PMID:
20685682
13.

ApoB/apoA-I ratio is better than LDL-C in detecting cardiovascular risk.

Carnevale Schianca GP, Pedrazzoli R, Onolfo S, Colli E, Cornetti E, Bergamasco L, Fra GP, Bartoli E.

Nutr Metab Cardiovasc Dis. 2011 Jun;21(6):406-11. doi: 10.1016/j.numecd.2009.11.002. Epub 2010 Feb 19.

PMID:
20171854
14.

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.

Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J.

Lancet. 2010 Jan 9;375(9709):132-40. doi: 10.1016/S0140-6736(09)61717-7. Epub 2009 Dec 22.

15.

Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.

Di Stefano R, Di Bello V, Barsotti MC, Grigoratos C, Armani C, Dell'Omodarme M, Carpi A, Balbarini A.

Biomed Pharmacother. 2009 Dec;63(10):773-80. doi: 10.1016/j.biopha.2009.06.004. Epub 2009 Oct 13.

PMID:
19906505
16.

C-reactive protein and coronary disease: is there a causal link?

Danesh J, Pepys MB.

Circulation. 2009 Nov 24;120(21):2036-9. doi: 10.1161/CIRCULATIONAHA.109.907212. Epub 2009 Nov 9. No abstract available.

17.

Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

Cziraky MJ, Watson KE, Talbert RL.

J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.

PMID:
19891279
18.

Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk.

Sharma RK, Singh VN, Reddy HK.

Vasc Health Risk Manag. 2009;5:793-9. Epub 2009 Sep 24. Review.

19.

[Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].

Kiliç T, Ural E, Oner G, Sahin T, Kiliç M, Yavuz S, Kanko M, Kahraman G, Bildirici U, Berki KT, Ural D.

Anadolu Kardiyol Derg. 2009 Aug;9(4):280-9. Turkish.

20.

Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis.

Vaverkova H, Karasek D, Novotny D, Jackuliakova D, Lukes J, Halenka M, Frohlich J.

Clin Biochem. 2009 Aug;42(12):1246-51. doi: 10.1016/j.clinbiochem.2009.05.004. Epub 2009 May 18.

PMID:
19450572

Supplemental Content

Support Center